Navigation Links
Drugs from the deep blue

rine natural products are an eclectic mix of chemical types, drawing on all the pathways of metabolism, Molinski said. Some are related to fats and proteins; others include elements such as bromine, sometimes bonded into improbable structures.

"It's a rich, complex and edited chemical library," Molinski said. "They're really fascinating little jewels made by niche creatures."

As well as being largely unexplored, the chemistry of these marine organisms is very different than that of land plants and animals, reflecting both a different environment and millions of years of separate evolution. That should make it harder for microbes to evolve resistance to such drugs, as they are being attacked from a completely different direction.

Molinski, a certified diver, and his graduate students make regular collecting trips to study sites in Micronesia, Western Australia and -- using a seagoing vessel, the R/V Seward Johnson based in Florida -- the Atlantic Ocean around the Bahamas. Warm tropical waters support a wider variety of sponges, making them richer prospecting grounds.

Back in the lab, the scientists put extracts from the animals they have collected through a battery of tests. If they find something with interesting properties, the researchers attempt to isolate and identify the molecule.

The next step is to start from conventional chemistry and make the compound in the lab, then try to find the simplest structure with the same properties. This work can pull in techniques from different areas of chemistry and biochemistry, but the pathways used to make these products naturally are far too complex to reproduce with current genetic engineering techniques, Molinski said.

One of their finds is phorboxazole, made by an Indian Ocean sponge collected by Molinski's team off the coast of Western Australia. Phorboxazole A is a potent toxin that in the laboratory, can inhibit the growth of a wide range of tumor cell types even at ve
'"/>

Source:University of California - Davis


Page: 1 2 3 4

Related biology news :

1. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
2. New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal
3. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
4. FDA Warns About Antipsychotic Drugs and Elderly
5. Computational Tool Predicts How Drugs Work In Cells, Advancing Efforts To Design Better Medicines
6. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
7. Engineered Stem Cells Show Promise For Sneaking Drugs Into The Brain
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drugs from the deep blue

(Date:10/17/2014)... in German . ... drugs. When treating overdoses, doctors are often limited to supportive ... there is a combination of drugs involved. So what can ... his grandmother,s pills? ETH professor Jean-Christophe Leroux from the Institute ... answer to this question. "The task was to develop an ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... our ability to assess the pandemic risk from strains ... we must not allow ourselves to become complacent that ... international consortium of scientists. , Influenza pandemics arise when ... yet to develop widespread immunity – spreads in the ... the past 100 years, the worst of which – ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2
... The 2010 Annual Meeting & OTO EXPO of the American ... the largest meeting of ear, nose, and throat doctors in ... official abstract supplement for the annual meeting is now available ... Otolaryngology Head and Neck Surgery . (See new ...
... a genetic route to understanding and treating epilepsy. Timothy ... has identified an ancient gene family that plays a role ... "In healthy people, nerves do not fire excessively in response ... on what really matters. Nerve cells maintain a threshold ...
... Eliza Hall Institute researchers in Melbourne, Australia, have made ... cell death and its role in tumour formation. ... process in human biology as it removes unwanted and ... against cancer development and autoimmune disease. The ...
Cached Biology News:Otolaryngology -- Head and Neck Surgery Annual Meeting supplement now available 2Epileptic seizures may be linked to an ancient gene family 2Missing Puma reveals cancer conundrum 2Missing Puma reveals cancer conundrum 3
(Date:10/18/2014)... (PRWEB) October 19, 2014 The ... (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin ... Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast ... major drivers, restraints, challenges, opportunities, current market trends, ... along with the estimates and forecasts of the ...
(Date:10/18/2014)... The Asian arthroscopic devices report defines and segments the ... revenue. The arthroscopic devices market in Asia is estimated ... CAGR of 6.5% from 2013 to 2018. , Browse ... to get an idea of the in-depth analysis provided. ... arthroscopic devices market in the same region, and is ...
(Date:10/18/2014)... The Asian Electronic Medical Record (EMR) market ... analysis and forecast of revenue. The electronic medical record market ... million by 2018, at a CAGR of 9.4% from 2013 ... Electronic Medical Record (EMR) market, to get an idea of ... the segmentation of the market in the same region, and ...
(Date:10/18/2014)... The report " Cloud Analytics ... Web; Speech; Machine; Video; Predictive Analytics: Global Advancements, ... & Analysis (2013 - 2018) ", defines and ... sub segments with an in-depth analysis and forecasting ... factors driving this market, various restraints, and opportunities ...
Breaking Biology Technology:Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 5The Asian arthroscopic devices market is estimated to grow to $712.3 million by 2018 - New Report by MicroMarket Monitor 2The Asian arthroscopic devices market is estimated to grow to $712.3 million by 2018 - New Report by MicroMarket Monitor 3The Asian arthroscopic devices market is estimated to grow to $712.3 million by 2018 - New Report by MicroMarket Monitor 4The Asian Electronic Medical Record (EMR) market is estimated to grow to $2,328.0 million by 2018 - New Report by MicroMarket Monitor 2The Asian Electronic Medical Record (EMR) market is estimated to grow to $2,328.0 million by 2018 - New Report by MicroMarket Monitor 3The Asian Electronic Medical Record (EMR) market is estimated to grow to $2,328.0 million by 2018 - New Report by MicroMarket Monitor 4The Asian Electronic Medical Record (EMR) market is estimated to grow to $2,328.0 million by 2018 - New Report by MicroMarket Monitor 5Cloud Analytics Market (by Cloud Business Intelligence & Predictive Analytics) Expected to Cross $16.52 Billion by 2018 - New Report by MarketsandMarkets 2Cloud Analytics Market (by Cloud Business Intelligence & Predictive Analytics) Expected to Cross $16.52 Billion by 2018 - New Report by MarketsandMarkets 3Cloud Analytics Market (by Cloud Business Intelligence & Predictive Analytics) Expected to Cross $16.52 Billion by 2018 - New Report by MarketsandMarkets 4Cloud Analytics Market (by Cloud Business Intelligence & Predictive Analytics) Expected to Cross $16.52 Billion by 2018 - New Report by MarketsandMarkets 5
... in ... ... CHDX ) a leading independent American provider of Western,healthcare services ... has agreed to an investment by JPMorgan,s Principal,Investment Management group. The ...
... Nov. 7 Transgenomic Inc. (OTC,Bulletin Board: TBIO) announces the following Webcast: ... Conference Call, ... Where: http://www.transgenomic.com/events.asp?id=6 , How: ... at the ...
... - Nventa,Biopharmaceuticals Corporation (TSX: NVN) announced today financial results,for ... unless,specified otherwise, are in Canadian dollars. Nventa reported ... share, for the,three months ended September 30, 2007, compared ... share, for the same period in 2006. For the ...
Cached Biology Technology:JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 2JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 3Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 3Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 4
... (ELISA) test kits are qualitative one-step kits ... of drugs and/or their metabolites in forensic ... use only. It is recommended that all ... method such as GC/MS. The simple ...
96 Well Base Plate...
... a recombinant human protein produced in E. coli ... RNase A type enzymes. The mode of ... in a 1:1 ratio. The enzyme has been ... and cell types. Addition of the ribonuclease inhibitor ...
... Inkjet Printer) is a revolutionary new ... Protein Macroarray Analysis, developed in conjunction ... strategy compliments established protocols in resolving ... proteins isoelectric point and apparent molecular ...
Biology Products: